Ruairi J Mackenzie
Technology Networks
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years, where he also worked on the site’s SEO and editorial AI strategies. He created the site’s podcast, Opinionated Science, in 2020. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
Got a question for Ruairi J Mackenzie?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 609
Industry Insight
Meet the Team Who Want To Develop Psychedelics Without the Hallucinations
There remains an active debate within the psychedelic community about the importance of psychedelic experiences to these drugs’ therapeutic effects. Delix Therapeutics is developing compounds, called psychoplastogens, that act similarly to psychedelic compounds at the molecular level but do not induce hallucinations. We spoke with the Delix team to find out more about their research's progress.
Article
Top Science News Stories of 2022
As the year ends, it’s time to reflect on the stories that you enjoyed the most. Here’s our roundup of this year’s most popular headlines, including new findings on how we humans age, the impact of diet on the microbiome and a revelation on the cause of multiple sclerosis (MS).
Article
What Gets Animals Fired Up? An Interview With Eppendorf & Science Prize Winner Ann Kennedy
Aggressive behavior is a routine behavior for species as diverse as mammals, birds and even insects. The brain activity underlying aggression has been the focus of Northwestern University assistant professor Ann Kennedy’s research. Kennedy, winner of the Eppendorf & Science Prize for Neurobiology, spoke with Technology Networks to discuss her work.
Article
The Top 10 Neuroscience Stories of 2022
From discoveries about the origins of multiple sclerosis to a potential new drug for Alzheimer’s disease – it has been a busy 2022 for the brain. After another huge year in neuroscience, we review 10 of the most important developments in the field.
News
Green Light May Reduce Chronic Pain Via the Brain’s Opioid System
A new study has unraveled the neural circuits that explain how green light can relieve some cases of chronic pain. The neurons ultimately activate the brain’s opioid system.
News
Laser Beam Brain Stimulation Could Boost Short-Term Memory by 25%
Shining a laser light at a targeted region of the human brain can boost short-term memory function by up to 25%, suggests a new study. The non-invasive technique could one day help improve attention deficits in people with ADHD (attention deficit hyperactivity disorder), say the paper’s authors.
News
Bass Gets Us Grooving, Even if We Can’t Actually Hear It
Even DJs who barely register above a “Paris Hilton” on the mixing aptitude scale know that flooding the dancefloor with bass can get a crowd moving. A new study suggests that at least some of this groove-inducing effect is due to sounds that the human ear can’t even perceive.
Infographic
How To Use Antibodies in Neuroscience
Antibodies are Y-shaped glycoproteins that play an important role in the immune system. Antibodies respond to foreign molecules entering the body, binding to and disabling these potential intruders. In this infographic, we explore several key uses for antibodies in neuroscience.
News
The FEDORA That May Increase Risk of Depression in Women
A small study examining both humans and mice has identified a gene regulator that may function as a controller of major depression specifically in females.
News
"Momentous" Breakthrough as Alzheimer’s Drug Modestly Slows Cognitive Decline
A new monoclonal antibody treatment can slow cognitive decline in people with early-stage Alzheimer’s disease, a study shows. The Eisai-developed drug, lecanemab, produced a small but robust effect.
Advertisement
